That's a good catch. Unfortunately, that is the outcome we most desire. I think it may have to do with the endpoint switch back to hospitalizations. Unlike McDonalds, the FDA is not lovin it.
ps. Good data opens the door to so many pathways that it is hard not to get excited. I like the addition of symptom data, but I think Revive didn't accumulate exactly what the FDA wants so there still needs to be negotiations and discussions. This is where we could use some expertise.
News 
Market Data 
Discover 
AI
